Surgery Rates Doubled for High-Risk Prostate Cancer | MedPage Today

Surgery Rates Doubled for High-Risk Prostate Cancer | MedPage Today

Meeting report from the prostate cancer foundation PSMA theranostics state of the science meeting - Miyahira - - The Prostate - Wiley Online Library

Meeting report from the prostate cancer foundation PSMA theranostics state of the science meeting - Miyahira - - The Prostate - Wiley Online Library

Mitoxantrone and Veliparib in Prostate Cancer: Updates from ASCO 2017 - YouTube

Mitoxantrone and Veliparib in Prostate Cancer: Updates from ASCO 2017 - YouTube

Risk calculators for men already on active surveillance | THE "NEW" PROSTATE CANCER INFOLINK

Risk calculators for men already on active surveillance | THE "NEW" PROSTATE CANCER INFOLINK

Protecting Your Bones and Improving Your Quality of Life During Prostate Cancer Treatment — Cancer ABCs

Protecting Your Bones and Improving Your Quality of Life During Prostate Cancer Treatment — Cancer ABCs

Abiraterone and enzalutamide had different adverse effects on the cardiovascular system: a systematic review with pairwise and network meta-analyses | Prostate Cancer and Prostatic Diseases

Abiraterone and enzalutamide had different adverse effects on the cardiovascular system: a systematic review with pairwise and network meta-analyses | Prostate Cancer and Prostatic Diseases

Prostatepedia Digest 8.28.2020

Prostatepedia Digest 8.28.2020

Prostate Cancer Treatment Protocols: Treatment Protocols

Prostate Cancer Treatment Protocols: Treatment Protocols

Prostate Cancer Staging: TNM Classification for Prostate Cancer

Prostate Cancer Staging: TNM Classification for Prostate Cancer

Deep-Learning Algorithm Grades Prostate Cancer Biopsy Specimens

Deep-Learning Algorithm Grades Prostate Cancer Biopsy Specimens

Optimizing the management of castration‐resistant prostate cancer patients: A practical guide for clinicians

onlinelibrary.wiley.com/doi/abs/10.1002/pros.24066?af=R

Who actually dies from prostate cancer? Additional observations | THE "NEW" PROSTATE CANCER INFOLINK

Who actually dies from prostate cancer? Additional observations | THE "NEW" PROSTATE CANCER INFOLINK

Dr. Trinh on How COVID-19 Has Impacted Surgical Decisions in Prostate Cancer - YouTube

Dr. Trinh on How COVID-19 Has Impacted Surgical Decisions in Prostate Cancer - YouTube

Circulating Tumor DNA in Metastatic Prostate Cancer - YouTube

Circulating Tumor DNA in Metastatic Prostate Cancer - YouTube

Who actually dies from prostate cancer? | THE "NEW" PROSTATE CANCER INFOLINK

Who actually dies from prostate cancer? | THE "NEW" PROSTATE CANCER INFOLINK

Genetic Risk Score for Prostate Cancer Screening - YouTube

Genetic Risk Score for Prostate Cancer Screening - YouTube

Synergy between radiation of metastases and immunotherapy confirmed | THE "NEW" PROSTATE CANCER INFOLINK

Synergy between radiation of metastases and immunotherapy confirmed | THE "NEW" PROSTATE CANCER INFOLINK

Diagnostic ability of Ga-68 PSMA PET to detect dominant and non-dominant tumors, upgrading and adverse pathology in patients with PIRADS 4–5 index lesions undergoing radical prostatectomy | Prostate Cancer and Prostatic Diseases

Diagnostic ability of Ga-68 PSMA PET to detect dominant and non-dominant tumors, upgrading and adverse pathology in patients with PIRADS 4–5 index lesions undergoing radical prostatectomy | Prostate Cancer and Prostatic Diseases

Dosing Begins in Trial of PET Imaging Agent for Prostate Cancer's Return

Dosing Begins in Trial of PET Imaging Agent for Prostate Cancer's Return

Prostatepedia Digest 8.21.2020

 Prostatepedia Digest 8.21.2020

Diagnostic ability of Ga-68 PSMA PET to detect dominant and non-dominant tumors, upgrading and adverse pathology in patients with PIRADS 4–5 index lesions undergoing radical prostatectomy | Prostate Cancer and Prostatic Diseases

Diagnostic ability of Ga-68 PSMA PET to detect dominant and non-dominant tumors, upgrading and adverse pathology in patients with PIRADS 4–5 index lesions undergoing radical prostatectomy | Prostate Cancer and Prostatic Diseases

Hormonal treatments for prostate cancer are often given late - Harvard Health Blog - Harvard Health Publishing

Hormonal treatments for prostate cancer are often given late - Harvard Health Blog - Harvard Health Publishing

Quantifying observational evidence for risk of dementia following androgen deprivation therapy for prostate cancer: an updated systematic review and meta-analysis | Prostate Cancer and Prostatic Diseases

Quantifying observational evidence for risk of dementia following androgen deprivation therapy for prostate cancer: an updated systematic review and meta-analysis | Prostate Cancer and Prostatic Diseases

Treatment of metastatic castration resistant prostate cancer with radium-223: a retrospective study at a US tertiary oncology center | Prostate Cancer and Prostatic Diseases

Treatment of metastatic castration resistant prostate cancer with radium-223: a retrospective study at a US tertiary oncology center | Prostate Cancer and Prostatic Diseases

Xconomy: Patient Death in Poseida Prostate Cancer Study Prompts Clinical Hold

Xconomy: Patient Death in Poseida Prostate Cancer Study Prompts Clinical Hold

Improving Specificity of PSA Screening w/ Serum & Urine Markers: Who Doesn’t Need a Prostate Biopsy? - YouTube

Improving Specificity of PSA Screening w/ Serum & Urine Markers: Who Doesn’t Need a Prostate Biopsy? - YouTube

Radium-223 in Metastatic CRPC - YouTube

Radium-223 in Metastatic CRPC - YouTube

Emerging Therapies for Advanced Prostate Cancer - YouTube

Emerging Therapies for Advanced Prostate Cancer - YouTube

Prostate Theranostics - What the Hell? — Cancer ABCs

Prostate Theranostics - What the Hell? — Cancer ABCs

miR Sentinel tests 90+ percent accurate in diagnosis of prostate cancer | THE "NEW" PROSTATE CANCER INFOLINK

miR Sentinel tests 90+ percent accurate in diagnosis of prostate cancer | THE "NEW" PROSTATE CANCER INFOLINK

miR Sentinel tests 90+ percent accurate in diagnosis of prostate cancer | THE "NEW" PROSTATE CANCER INFOLINK

miR Sentinel tests 90+ percent accurate in diagnosis of prostate cancer | THE "NEW" PROSTATE CANCER INFOLINK

Surgical vs Intermittent Castration for Prostate Cancer - YouTube

Surgical vs Intermittent Castration for Prostate Cancer - YouTube

Lower COVID-19 Risk With ADT for Prostate Cancer | MedPage Today

Lower COVID-19 Risk With ADT for Prostate Cancer | MedPage Today

Prostatepedia Digest 8.14.2020

Prostatepedia Digest 8.14.2020

Prostate Cancer Debate: Treatment strategies and options in castration-resistant prostate cancer - YouTube

Prostate Cancer Debate: Treatment strategies and options in castration-resistant prostate cancer - YouTube

Optimizing the management of castration‐resistant prostate cancer patients: A practical guide for clinicians - Shore - - The Prostate - Wiley Online Library

Optimizing the management of castration‐resistant prostate cancer patients: A practical guide for clinicians - Shore - - The Prostate - Wiley Online Library

The Movember Prostate Cancer Landscape Analysis: an assessment of unmet research needs | Nature Reviews Urology

The Movember Prostate Cancer Landscape Analysis: an assessment of unmet research needs | Nature Reviews Urology

Neoadjuvant CHT + surgery for men with high-risk, localized prostate cancer | THE "NEW" PROSTATE CANCER INFOLINK

Neoadjuvant CHT + surgery for men with high-risk, localized prostate cancer | THE "NEW" PROSTATE CANCER INFOLINK

Prostatepedia Digest 8.7.2020

Prostatepedia Digest 8.7.2020

Beyond PSA: New Prostate Cancer Screening Options

Beyond PSA: New Prostate Cancer Screening Options

A Call to Test Men With Prostate Cancer for COVID-19

A Call to Test Men With Prostate Cancer for COVID-19

PSA doubling time and prognosis for men with nmCRPC | THE "NEW" PROSTATE CANCER INFOLINK

PSA doubling time and prognosis for men with nmCRPC | THE "NEW" PROSTATE CANCER INFOLINK

Impact of 68Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single-Center Study

Impact of 68Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single-Center Study